Literature DB >> 9361074

Craniopharyngiomas in two consanguineous siblings: case report.

A L Boch1, R van Effenterre, M Kujas.   

Abstract

OBJECTIVE AND IMPORTANCE: We describe a double case of craniopharyngioma in consanguineous siblings, suggesting the disease is sometimes genetic. CLINICAL
PRESENTATION: Two typical adamantine craniopharyngiomas were observed in two consanguineous siblings. The brother and the sister, whose parents were first cousins, developed the tumors at the same age. INTERVENTION: The male patient was operated on using a frontopterional approach, and the tumor was completely resected. The patient remained free from recurrence 9 years after surgery. His older sister died after tumor removal was attempted at another institution.
CONCLUSION: To our knowledge, such a connection has never been reported in the literature. It suggests that craniopharyngioma, which is usually sporadic, can also be transmitted in an autosomal recessive manner.

Entities:  

Mesh:

Year:  1997        PMID: 9361074     DOI: 10.1097/00006123-199711000-00031

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  3 in total

1.  Childhood craniopharyngioma in Macedonia: incidence and outcome after subtotal resection and cranial irradiation.

Authors:  Zoran S Gucev; Dragan Danilovski; Velibor Tasic; Jovica Ugrinovski; Vesna Nastova; Aleksandra Jancevska; Marina Krstevska-Konstantinova; Nada Pop-Jordanova; Ilija Kirovski
Journal:  World J Pediatr       Date:  2010-12-30       Impact factor: 2.764

Review 2.  A systematic review of the results of surgery and radiotherapy on tumor control for pediatric craniopharyngioma.

Authors:  Aaron J Clark; Tene A Cage; Derick Aranda; Andrew T Parsa; Peter P Sun; Kurtis I Auguste; Nalin Gupta
Journal:  Childs Nerv Syst       Date:  2012-10-23       Impact factor: 1.475

3.  Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma.

Authors:  Michael E Sughrue; Isaac Yang; Ari J Kane; Shanna Fang; Aaron J Clark; Derrick Aranda; Igor J Barani; Andrew T Parsa
Journal:  J Neurooncol       Date:  2010-06-10       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.